FDA broke agency protocol by inappropriately "collaborating" with Biogen to approve Alzheimer's drug
Two House of Representatives committees – Oversight and Reform, and Energy and Commerce – have published a report exposing the Food and Drug Administration (FDA) for "collaborat[ing]" [...]
Source: naturalnews.com